Trouble reading this email? View it in your browser
European Federation of Pharmaceutical Industries and Associations EFPIA Newsletter 17 December 2020
      News
 
  15 December 2020 EFPIA Response to the European Commission's Roadmap on a Green Paper on Ageing

EFPIA welcomes the European Commission’s work on a Green Paper on Ageing aiming at fostering solutions to one of Europe’s...

Read more →
 
 
 
  11 December 2020 Joint Press Statement of European Pharmaceutical Industry Associations

on the Commission’s Update on the Progress and Implementation of the European Union Strategic Approach to Pharmaceuticals...

Read more →
 
 
 
      Blogs
 
  17 December 2020 Drug shortages: Lessons from the COVID-19 crisis

Everything you always wanted to know about drug shortages (but were afraid to ask)

Read more →
 
 
 
  16 December 2020 Alzheimer’s treatments in development could launch a new era in dementia care

With new therapies on the horizon, we may be at a turning point. Patients, experts and industry agree that now is the...

Read more →
 
 
 
  15 December 2020 Podcast: Have you dropped the ball on antimicrobial resistance (AMR)?

Welcome to 19 conversations

Read more →
 
 
 
  14 December 2020 Introducing new cancer treatments: how reducing time to market access dramatically impacts...

Every Day Counts

Read more →
 
 
 
      Videos
 
 
 
#WeWontRest until there is a COVID-19 vaccine for everyone
Safety remains our key priority. COVID-19 vaccines undergo the same rigorous studies, approval process and objective review by the EMA and other global regulators, as any vaccine. We will never compromise on safety.
 
 
Biogen: Working Together Towards Better Patient Outcomes
The progressive nature of Spinal Muscular Atrophy (SMA) means that the sooner someone is diagnosed; the sooner intervention can be made with treatments that can change the course of the disease.
 
 
 
 
 
Grünenthal: Working Together Towards Better Patient Outcomes
This special report on pain features Grünenthal, who sees palliative care as a moral duty and human right and believes that end of life care should be achievable and accessible worldwide. Grünenthal has developed comprehensive care systems that include psychological, spiritual and social support for the patient and their families.
 
 
Leo Pharma: Working Together Towards Better Patient Outcomes
Leo Pharma works in partnership with patients to gain a better understanding of diseases and chronic conditions, and the treatment plan that is needed. The company feels it is vital for patients to be involved in all the key steps as nobody is more informed than someone living with the condition.
 
 
 
 
      Events
 
 
12 JAN 2021
  PSI EIWG Webinar: PIONEERing estimands in Clinical Research Virtual event

EFPIA and the EFSPI estimand implementation working group (EIWG) are hosting a webinar to illustrate the new ICH E9(R1)...

Learn more →
 
 
 
31 JAN 2021
  Enter the EURORDIS Photo Award 2020 Online Award

The EURORDIS Photo Award is an opportunity to visually express what it means to live with a rare disease and to share...

Learn more →
 
 
 
04 FEB 2021
  How Can Europe Enhance the Benefits of AI-Enabled Health Care? Virtual event

Organised by the Center for Data Innovation

Learn more →
 
 
 
04 MAR 2021
  Value Based Healthcare Conference – Tallinn 2021 Virtual event

The conference aims at raising awareness and knowledge among the healthcare community on the value of patient-centered...

Learn more →
 
 
      Our latest publications
    About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

 
Tel: +32 (0)2 626 25 55
Communications@efpia.eu
▶ in
 
EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe